glp-1 addiction treatment GLP-1s and Treatment: Setting a Thoughtful Standard GLP-1 and Addiction: Clinical Trials

A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes

Im seeing real positive impact in my patients in clinic every day

Because compounded medications are not FDA-approved, transparency around pharmacy oversight, preparation standards, and testing can help consumers better understand how a medication is prepared and monitored

It plays a role in muscle development, cellular growth, and metabolism

Patients with pre-existing kidney or liver conditions should not use this treatment without full medical clearance from their physician